These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4318569)

  • 1. Hepatoma: long-term survival with disseminated tumor treated with 5-fluorouracil.
    Ramirez G; Ansfield FJ; Curreri AR
    Am J Surg; 1970 Sep; 120(3):400-3. PubMed ID: 4318569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)].
    Cavalli F; Tschopp L; Gerber A; Sonntag RW; Ryssel HJ; Brunner KW
    Schweiz Med Wochenschr; 1977 Dec; 107(52):1960-6. PubMed ID: 202020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival with hepatocellular carcinoma.
    Penalba C; Larouze B; Mechali D; Saimot G; Coulaud JP
    Gastroenterology; 1982 Nov; 83(5):1159. PubMed ID: 6288508
    [No Abstract]   [Full Text] [Related]  

  • 4. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
    Baker LH; Saiki JH; Jones SE; Hewlett JS; Brownlee RW; Stephens RL; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1595-7. PubMed ID: 200359
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intra-arterial treatment of malignant neoplasms in children (author's transl)].
    Czerwiński W
    Probl Med Wieku Rozwoj; 1972; 2():189-97. PubMed ID: 4142087
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complete disappearance of metastatic lung tumors and mediastinal lymphnode in a case of hepatocellular carcinoma treated by low-dose 5-fluorouracil/cisplatin therapy].
    Anami Y; Oguma S; Matsuda Y; Yamaki T; Sazawa Y; Komiya H; Izai J; Ota T
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1977-80. PubMed ID: 16282739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polychemotherapy of bronchial carcinoma].
    Fazio M; Minetto E; Cavallero P; Sartoris S
    Minerva Med; 1970 Jun; 61(46):2567-70. PubMed ID: 5425737
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous prolonged intrahepatic infusion of 5-fluorouracil in the treatment of hepatoma in Ibadan.
    Francis TI
    West Afr Med J Niger Pract; 1972 Feb; 21(1):18-20. PubMed ID: 4338412
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with infusion and resection in cancer of the liver.
    Stehlin JS; Hafström L; Greeff PJ
    Surg Gynecol Obstet; 1974 Jun; 138(6):855-63. PubMed ID: 4363781
    [No Abstract]   [Full Text] [Related]  

  • 10. [Apropos of a hepatoma: rôle of regional chemotherapy].
    Bessot M; Thevenin F; Fays J; Grilliat JP
    Sem Hop; 1968 Jun; 44(29):1995-6. PubMed ID: 4299982
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of cancer of the liver by regional perfusion].
    Bessot M; Duprez A
    J Chir (Paris); 1968 Feb; 95(2):185-202. PubMed ID: 4302978
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
    Tsurumachi T; Yamamoto H; Watanabe K; Honda I; Watanabe S; Yamada S; Jingu K; Satomi D; Fujita M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):631-4. PubMed ID: 8678524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of advanced hepatocellular carcinoma with lung metastases and cirrhosis that responded to combination chemotherapy with interferon-alpha and 5-fluorouracil].
    Shitara K; Munakata M; Kudo T; Muto O; Okada R; Mitobe S; Sakata Y; Kondo M; Ishii E; Yabu K
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2083-6. PubMed ID: 17197759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma responding to chemotherapy with 5-FU.
    Yoshida H; Onda M; Tajiri T; Umehara M; Mamada Y; Taniai N; Kaneko M; Mizuguchi Y; Uchida E; Yamashita K; Uchida E
    Hepatogastroenterology; 2000; 47(34):1120-1. PubMed ID: 11020893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy.
    Jiang W; Lu Z; He Y; Diasio RB
    Clin Cancer Res; 1997 Mar; 3(3):395-9. PubMed ID: 9815697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with hepatic arterial infusions.
    Sanderson TA; McBride CM
    Tex Med; 1971 Mar; 67(3):52-6. PubMed ID: 4326061
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
    Asano N; Fukano M; Kubo M; Sato J; Ito A; Inoue T; Tsujikawa T; Ando A; Sasaki M; Yoshioka U; Koyama S; Fujiyama Y; Bamba T
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1069-73. PubMed ID: 9644322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients treated with systemic fluorouracil for hepatic metastases.
    Rapoport AH; Burleson RL
    Surg Gynecol Obstet; 1970 May; 130(5):773-7. PubMed ID: 5440763
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatoma, erythrocytosis and increased serum erythropoietin developing in long-standing hemochromatosis.
    Scott D; Theologides A
    Am J Gastroenterol; 1974 Mar; 61(3):206-11. PubMed ID: 4363553
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
    Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC
    J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.